RK Pharma key facts
- Manufacturer of generic pharmaceutical products designed to focus on products with formulation challenges and first generic opportunities.
- It has raised $25.0M; the latest was PE Growth/Expansion ($25.0M) in Nov 2025.
- Notable investors include PAG, Signet Healthcare Partners.
- Status: Privately Held (backing).
Who backs RK Pharma
2- ·Watch RK Pharma: the Monday email on marks, rounds and moves
RK Pharma funding rounds
No funding rounds for RK Pharma are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
RK Pharma investors
2 investors are on record for RK Pharma, including PAG and Signet Healthcare Partners.
About RK Pharma
Manufacturer of generic pharmaceutical products designed to focus on products with formulation challenges and first generic opportunities. The company specializes in managing a seamless process of bulk manufacturing through multi-format packaging and end-product release testing suited for injectables, sterile ophthalmic and dermal products, enabling clients to get a broad range of affordable and effective therapeutic products for patients.
- Sector
- Healthcare
- HQ
- Pearl River, NY, United States
- Founded
- 2003
- Employees
- 1,700
- Website
- rkpharmainc.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
RK Pharma doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.